Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Beta Bionics, Inc. Director's Dealing 2026

Jan 15, 2026

32351_dirs_2026-01-14_b3ffd4d7-29e5-4a13-8311-dbda39356d3b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2026-01-13

Reporting Person: Palasis Maria (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-01-13 Common Stock A 3997 Acquired 12432 Direct

Footnotes

F1: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.